百濟神州（BeiGene）百悅澤®（澤布替尼）獲歐盟委員會批准，用於治療慢性淋巴細胞白血病成人患者
PR Newswire Asia· 2 週前百悅澤®是唯一在復發/難治性慢性淋巴細胞白血病（CLL）中對比億珂®（伊布替尼）獲得優效性的布魯頓氏酪氨酸激酶（BTK）抑制劑 百悅澤®在既往未經治療的CLL ...
AllianceBernstein: Can Multi-Asset Approaches Balance Sustainable Investing Risks?
ACCESSWIRE· 3 週前NORTHAMPTON, MA / ACCESSWIRE / November 11, 2022 / AllianceBernstein Investors who opt for a ...
Advancing Sustainability and Transparency on the ESG Journey
ACCESSWIRE· 3 週前The 2020s are shaping up to be a transformative era of impact. Increasingly, investors, ...
核研所遭爆人事升遷舞弊案 原能會：3篇研究報告已先下架
中廣新聞網 via Yahoo奇摩新聞· 1 個月前原能會核能研究所爆出人事升遷舞弊案，原能會回應，年初便籌組專案小組啟動調查，經初步檢視，有3篇研 ...
Wells Fargo Foundation Awards New Philadelphia Collaborative $7.5 Million To Boost Homeownership
ACCESSWIRE· 1 個月前U.S. Congressman Dwight Evans and members of Philadelphia City Council joined the Urban League ...
Father's Hard Work Leads to Daughter's American Dream
ACCESSWIRE· 1 個月前When you ask William Rodriguez, a single father of two, the most important lessons he's ...
Optimizing Assets for Mission
ACCESSWIRE· 1 個月前In our earliest days, this meant expanding our philanthropic toolbox; growing it from grants ...
【許偉帆醫師】全面解析C肝傳染途徑！肝膽腸胃科醫師警告：這樣做「陽性比例高達九成」
問8健康新聞網 via Yahoo奇摩新聞· 3 個月前C型肝炎病毒 (Hepatitis C virus, HCV)所造成的感染，是全世界常見的慢性肝臟疾病之一，也是台灣僅次 ...
信達生物 IBI311（抗IGF-1R抗體）臨床I期研究完成首例給葯
PR Newswire Asia· 4 個月前美國三藩市和中國蘇州2022年8月18日 /美通社/ -- 信達生物製藥集團（香港聯交所股票代碼：01801），一家致力於研發、生產和銷售腫瘤、自免、代謝、眼科等重 ...
Ethereum developer sees crypto impacting 'every corner of society'
Yahoo財經· 4 個月前Lane Rettig, one of Etherium’s (ETH-USD) former core developers, says crypto could change ...
